Drugs / DCN01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01853722 | Apr → Jul 2013 | eye infectious disorder | Deacon Biosciences, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DCN01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01853722 ↗ |
| Route | Topical | “Following Topical Periocular Administration” NCT01853722 ↗ |